Overview

Laser Ablation Versus Mechanochemical Ablation Trial

Status:
Active, not recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency.
Phase:
Phase 4
Details
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
University of Hull
Treatments:
Epinephrine
Epinephryl borate
Lidocaine
Pharmaceutical Solutions
Racepinephrine
Sodium Tetradecyl Sulfate